22:30:08 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-28 Kvartalsrapport 2024-Q3
2024-09-04 Kvartalsrapport 2024-Q2
2024-05-29 Kvartalsrapport 2024-Q1
2024-05-08 X-dag ordinarie utdelning ANDF 0.00 NOK
2024-05-07 Årsstämma
2024-02-29 Bokslutskommuniké 2023
2023-11-30 Kvartalsrapport 2023-Q3
2023-09-14 Kvartalsrapport 2023-Q2
2023-07-06 Extra Bolagsstämma 2023
2023-05-25 Kvartalsrapport 2023-Q1
2023-05-12 X-dag ordinarie utdelning ANDF 0.00 NOK
2023-05-12 Årsstämma
2023-03-16 Bokslutskommuniké 2022
2022-12-02 Kvartalsrapport 2022-Q3
2022-09-15 Kvartalsrapport 2022-Q2
2022-07-01 Extra Bolagsstämma 2022
2022-06-03 Kvartalsrapport 2022-Q1
2022-04-29 X-dag ordinarie utdelning ANDF 0.00 NOK
2022-04-28 Årsstämma
2022-03-23 Bokslutskommuniké 2021
2021-12-03 Kvartalsrapport 2021-Q3
2021-10-13 Extra Bolagsstämma 2021
2021-09-03 Kvartalsrapport 2021-Q2
2021-06-04 Kvartalsrapport 2021-Q1
2021-05-07 X-dag ordinarie utdelning ANDF 0.00 NOK
2021-05-06 Årsstämma
2021-03-12 Bokslutskommuniké 2020
2020-12-02 Kvartalsrapport 2020-Q3
2020-09-02 Kvartalsrapport 2020-Q2

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHandel & varor
IndustriDagligvaror
Andfjord Salmon Group är ett norskt bolag som bedriver fiskodling. Bolaget förfogar över egna produktionsanläggningar runtom den norska hemmamarknaden, med störst fokus på odling av lax. En stor del av verksamheten fokuserar mot utvecklandet av nya metoder och produktionsprocesser. Kunderna återfinns huvudsakligen bland grossister samt bland företag och restauranger inom livsmedelsbranschen.
2024-05-22 23:36:37
22.5.2024 23:36:34 CEST | Andfjord Salmon | Additional regulated information
required to be disclosed under the laws of a member state

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN
AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S
REPUBLIC OF CHINA, SOUTH AFRICA, NEW ZEALAND, JAPAN OR THE UNITED STATES, OR ANY
OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE
UNLAWFUL

Reference is made to the stock exchange announcement by Andfjord Salmon Group AS
("Andfjord Salmon" or the "Company") on 22 May 2024 regarding the contemplated
private placement of new shares (the "Offer Shares").

The Company hereby announces that it has allocated 10,606,060 Offer Shares at a
subscription price of NOK 33 per share (the "Offer Price"), raising gross
proceeds of approximately NOK 350 million (the "Private Placement"). ABG Sundal
Collier ASA, Arctic Securities AS, DNB Markets (a part of DNB Bank ASA) and
SpareBank 1 Markets are acting as Joint Bookrunners (the "Joint Bookrunners") in
connection with the Private Placement. The net proceeds from the Private
Placement will be used to expand the Company's production capacity at Kvalnes,
ramping up biomass and for general corporate purposes.

The following primary insiders were allocated Offer Shares at the Offer Price:

* Jerónimo Martins Agro-Alimentar, S.A., represented on the board of directors
by Antonio Serrano, was allocated 2,636,362 Offer Shares

* Eidsfjord Sjøfarm AS, represented on the board of directors by Knut Holmøy,
was allocated 481,515 Offer Shares

The Offer Shares are expected to be settled on a delivery versus payment basis
on or about 27 May 2024 by delivery of existing and unencumbered shares in the
Company that are already listed on Euronext Growth Oslo pursuant to a share
lending agreement (the "Share Lending Agreement") entered into between the
Company, Andfjord Holding AS, Skagerak Vekst AS, OG Invest AS, SpareBank 1
Markets and the Joint Bookrunners. The Offer Shares will, as allocated, be
tradable upon allocation. The new shares were resolved issued by the Company's
board of directors pursuant to the board authorisation (the "Board Authorisation
") granted by the annual general meeting of the Company held on 7 May 2024, and
will be used to settle the share loan pursuant to the Share Lending Agreement.

Completion of the Private Placement is subject to registration of the share
capital increase in the Norwegian Register of Business Enterprises and the Offer
Shares being validly issued and registered with the Norwegian Central Securities
Depository (VPS). The settlement of Offer Shares will remain final and binding
and cannot be revoked, cancelled or terminated by the respective applicants.
Following registration of the new share capital pertaining to the Private
Placement, the Company will have a share capital of NOK 67,619,013 divided into
67,619,013 shares, each with a par value of NOK 1.00.

The Private Placement involves that the shareholders' preferential rights to
subscribe for and be allocated the Offer Shares are set aside. The Board has
considered the structure of the equity raise in light of the equal treatment
obligations under the Norwegian Private Limited Companies Act, the rules on
equal treatment under Euronext Oslo Rule Book Part II and the Oslo Stock
Exchange's Guidelines on the rule of equal treatment. The Board is of the view
that it is in the common interest of the Company and its shareholders to raise
equity through the Private Placement. The Private Placement enables the Company
to secure equity financing to expand the Company's production capacity at
Kvalnes, ramping up biomass and for general corporate purposes. Further, a
private placement will reduce execution and completion risk and allows for the
Company to utilize current market conditions and raise capital more quickly, at
a lower discount compared to a rights issue and without the underwriting
commissions normally seen with rights offerings. Further, the Subsequent
Offering (as defined below), if implemented, will secure that eligible
shareholders will receive the opportunity to subscribe for new shares at the
same subscription price as that applied in the Private Placement. On this basis
the Board has considered the proposed transaction structure to be in the common
interest of the Company and its shareholders.

The Company intends to carry out a subsequent offering (the "Subsequent
Offering") with non-tradeable subscription rights of up to 796,530 new shares in
the Company which, subject to applicable securities law, will be directed
towards existing shareholders in the Company as of 22 May 2024 (as registered in
the VPS two trading days thereafter), who (i) were not allocated Offer Shares in
the Private Placement, and (ii) are not resident in a jurisdiction where such
offering would be unlawful or, would (in jurisdictions other than Norway)
require any prospectus, filing, registration or similar action. Whether or not
such Subsequent Offering will ultimately take place, will depend inter alia on
the development of the price of the shares in the Company after completion of
the Private Placement. Further, the Subsequent Offering is subject to, inter
alia, completion of the Private Placement, approval by the board of directors,
and the publication of an offering prospectus.

Advokatfirmaet Schjødt AS is acting as legal advisor to the Company in
connection with the Private Placement.

CONTACTS

* Bjarne Martinsen, CFO, Andfjord Salmon AS, +47 975 08 345,
bjarne.martinsen@andfjord.no
* Media: Martin Rasmussen, CEO, Andfjord Salmon AS, +47 975 08 665,
martin@andfjord.no

ABOUT ANDFJORD SALMON

Located at Andøya on the Arctic Archipelago of Vesterålen, Norway, Andfjord
Salmon is developing the world's most sustainable and fish-friendly aquaculture
facility of its kind. Through a proprietary flow-through system, Andfjord Salmon
combines the best from ocean and land-based salmon farming. In its first
production cycle, the company achieved an industry-leading survival rate of 97.5
percent, feed conversion ratio of 1.05, superior share of 91.1 percent, and
required 1 kWh to produce one kilo of salmon. Andfjord Salmon has identified a
roadmap towards a production capacity of 40,000 tonnes HOG at Kvalnes, Andøya,
and set a long-term ambition to reach 90,000 tonnes HOG across Kvalnes, Breivika
and Fiskenes at Andøya. For more information, see www.andfjordsalmon.com -
https://www.andfjordsalmon.com.

IMPORTANT NOTICES

This announcement is not and does not form a part of any offer to sell, or a
solicitation of an offer to purchase, any securities of the Company. The
distribution of this announcement and other information may be restricted by law
in certain jurisdictions. Copies of this announcement are not being made and may
not be distributed or sent into any jurisdiction in which such distribution
would be unlawful or would require registration or other measures. Persons into
whose possession this announcement or such other information should come are
required to inform themselves about and to observe any such restrictions. The
securities referred to in this announcement have not been and will not be
registered under the U.S. Securities Act of 1933, as amended (the "Securities
Act"), and accordingly may not be offered or sold in the United States absent
registration or an applicable exemption from the registration requirements of
the Securities Act and in accordance with applicable U.S. state securities laws.
The Company does not intend to register any part of the offering or their
securities in the United States or to conduct a public offering of securities in
the United States. Any sale in the United States of the securities mentioned in
this announcement will be made solely to "qualified institutional buyers" as
defined in Rule 144A under the Securities Act. In any EEA Member State, this
communication is only addressed to and is only directed at qualified investors
in that Member State within the meaning of the Prospectus Regulation, i.e., only
to investors who can receive the offer without an approved prospectus in such
EEA Member State. The expression "Prospectus Regulation" means Regulation
2017/1129 as amended together with any applicable implementing measures in any
Member State. This communication is only being distributed to and is only
directed at persons in the United Kingdom that are (i) investment professionals
falling within Article 19(5) of the Financial Services and Markets Act 2000
(Financial Promotion) Order 2005, as amended (the "Order") or (ii) high net
worth entities, and other persons to whom this announcement may lawfully be
communicated, falling within Article 49(2)(a) to (d) of the Order (all such
persons together being referred to as "relevant persons"). This communication
must not be acted on or relied on by persons who are not relevant persons. Any
investment or investment activity to which this communication relates is
available only for relevant persons and will be engaged in only with relevant
persons. Persons distributing this communication must satisfy themselves that it
is lawful to do so. Matters discussed in this announcement may constitute
forward-looking statements. Forward-looking statements are statements that are
not historical facts and may be identified by words such as "believe", "expect",
"anticipate", "strategy", "intends", "estimate", "will", "may", "continue",
"should" and similar expressions. The forward-looking statements in this release
are based upon various assumptions, many of which are based, in turn, upon
further assumptions. Although the Company believes that these assumptions were
reasonable when made, these assumptions are inherently subject to significant
known and unknown risks, uncertainties, contingencies and other important
factors which are difficult or impossible to predict and are beyond its control.
Actual events may differ significantly from any anticipated development due to a
number of factors, including without limitation, changes in investment levels
and need for the Company's services, changes in the general economic, political
and market conditions in the markets in which the Company operate, the Company's
ability to attract, retain and motivate qualified personnel, changes in the
Company's ability to engage in commercially acceptable acquisitions and
strategic investments, and changes in laws and regulation and the potential
impact of legal proceedings and actions. Such risks, uncertainties,
contingencies and other important factors could cause actual events to differ
materially from the expectations expressed or implied in this release by such
forward-looking statements. The Company does not provide any guarantees that the
assumptions underlying the forward-looking statements in this announcement are
free from errors nor does it accept any responsibility for the future accuracy
of the opinions expressed in this announcement or any obligation to update or
revise the statements in this announcement to reflect subsequent events. You
should not place undue reliance on the forward-looking statements in this
document. The information, opinions and forward-looking statements contained in
this announcement speak only as at its date, and are subject to change without
notice. The Company does not undertake any obligation to review, update,
confirm, or to release publicly any revisions to any forward-looking statements
to reflect events that occur or circumstances that arise in relation to the
content of this announcement. Neither of the Joint Bookrunners nor any of their
respective affiliates makes any representation as to the accuracy or
completeness of this announcement and none of them accepts any responsibility
for the contents of this announcement or any matters referred to herein. This
announcement is for information purposes only and is not to be relied upon in
substitution for the exercise of independent judgment. It is not intended as
investment advice and under no circumstances is it to be used or considered as
an offer to sell, or a solicitation of an offer to buy any securities or a
recommendation to buy or sell any securities in the Company. Neither the Joint
Bookrunners nor any of their respective affiliates accepts any liability arising
from the use of this announcement.